Portal de Periódicos da CAPES

Hyaluronic acid grafting mitigates calcification of glutaraldehyde‐fixed bovine pericardium

2004; Wiley; Volume: 70A; Issue: 2 Linguagem: Inglês

10.1002/jbm.a.30088

1552-4965

Rachit Ohri, Sei Kwang Hahn, Allan S. Hoffman, Patrick S. Stayton, Cecilia M. Giachelli,

Endodontics and Root Canal Treatments

Pathologic calcification is the leading cause of the clinical failure of glutaraldehyde-fixed bovine pericardium used in bioprosthetic valves. A novel surface modification of glutaraldehyde fixed bovine pericardium was carried out with high molecular weight hyaluronic acid (HA). HA was chemically modified with adipic dihydrazide (ADH) to introduce hydrazide functional groups onto the HA backbone. Glutaraldehyde-fixed bovine pericardium (GFBP) was modified by grafting this HA to the free aldehyde groups on the tissue via the hydrazide groups. Following a 2-week subcutaneous implantation in osteopontin (OPN)-null mice, the calcification of HA-modified bovine pericardium was drastically reduced (by 84.5%) compared to positive controls (tissue without HA-modification) (p = 0.005). The calcification-mitigating effect of HA surface modification was also confirmed by microscopic analysis of explanted tissue stained with Alizarin Red S for calcium.